Latest / The BioHub - by Avetix
Episode 35 - David Esposito, CEO ONL Therapeutics
Thank you for tuning into another episode of Bio Hub! Today, we have the privilege of hosting David Esposito, a seasoned leader in the biotech industry and the CEO of ONL Therapeutics. David's experience is vast, spanning over two decades in leadership roles across the biotech landscape. He has previously served as President and CEO of Armune Biosciences, VP Commercial Operations at Thermo Fisher, and Executive Director Commercial Strategy at Merck.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.